Please enter your details to request more information

INVEST IN A WORLD-CLASS AI COMPANY PARTNERED WITH A UK GOVERNMENT AGENCY

• 230% conservative short term growth*
• 42.2% CAGR of the AI-Healthcare Market
• 30% Tax Relief (EIS Approved)

Investment Highlights

• HRMC EIS APPROVED – 30% Tax Relief
• Government Backed – Supported by a UK Government Grant
• Explosive Growth - £10,499,250 EBITDA forecast by Year 3
• Long Term Expansion - £33m Total Revue forecast by year 5
• Access to the most extensive biological datasets in the UK
• Unmatched medical research capabilities
• Enables machine-to-machine AI Connectivity

ChiefAI have built a world-class AI infrastructure designed to deliver never-before-seen levels of healthcare analytics and predictive oncology. We are partnered with The Medicines Discovery Catapult; a government agency and under an Innovate UK Government grant.

Example Returns*

values are in £

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring you consent to being contacted and you consent to your data being stored in accordance with European GDPR regulations. Privacy Policy

Disclaimer: Any person accessing this website or page and considering potential investment opportunities featured here, should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This website or page should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. Suitable appropriately qualified investors, sophisticated and high net worth investors only.

*Based on company forecasts. See investment memorandum for more details